OVARY CANCER

This study is testing a new type of personalized cell therapy for adults with advanced solid tumors that have returned or spread. The therapy, called Tmod CAR T cells, is designed to find and kill cancer cells while trying to avoid harming the patient's healthy cells. Researchers…

This study is testing whether a combination of two drugs, mirvetuximab soravtansine and olaparib, can help keep cancer from growing back in women whose ovarian, peritoneal, or fallopian tube cancer has returned but responded well to platinum-based chemotherapy. The goal is to see…

This study is testing whether a combination of two oral drugs, senaparib and temozolomide, can shrink tumors in women with a specific type of recurrent ovarian cancer that has a genetic change called ARID1A. It is for women whose cancer has come back after prior treatments. The m…

This early-stage trial tests whether a patient's own immune cells can be genetically modified to recognize and attack their cancer. The study is for adults with advanced cancers that have spread and express a specific marker called NY-ESO-1. Researchers will first find the safest…

This study is testing whether some ovarian cancer patients can safely skip getting a temporary stoma bag (an opening in the abdomen for waste) after major bowel surgery. Researchers want to see if carefully selected 'low-risk' patients heal just as well without this common proced…

This study is testing whether drinking tart cherry juice can prevent nerve pain (neuropathy) caused by a common chemotherapy drug called paclitaxel. It will enroll 86 people with breast or ovarian cancer who are starting this type of chemo. Participants will be randomly assigned …

This study is testing whether showing educational videos to patients can increase how many people with ovarian or endometrial cancer get recommended genetic testing. Researchers will enroll 30 patients to watch a video and may ask them to complete a survey. They will then check m…